scholarly journals Biodegradation of porous calcium phosphate scaffolds in an ectopic bone formation model studied by X-ray computed microtomograph

2010 ◽  
Vol 19 ◽  
pp. 136-146 ◽  
Author(s):  
VS Komlev ◽  
◽  
M Mastrogiacomo ◽  
RC Pereira ◽  
F Peyrin ◽  
...  
2001 ◽  
Vol 108 (2) ◽  
pp. 434-443 ◽  
Author(s):  
Johan W. M. Vehof ◽  
Javed Mahmood ◽  
Hiroko Takita ◽  
Martin A. vanʼt Hof ◽  
Yoshinori Kuboki ◽  
...  

Coatings ◽  
2021 ◽  
Vol 11 (10) ◽  
pp. 1195
Author(s):  
Henri J. J. Uijlenbroek ◽  
Xingnan Lin ◽  
Xin Zhang ◽  
Liquan Deng ◽  
Daniel Wismeijer ◽  
...  

In order to evaluate loading methods and the dose dependency of bone morphogenetic protein 2 (BMP-2) in ectopic bone formation, an osteoinductive material consisting of commercially available coralline hydroxyapatite (CHA) was coated with a layer of biomimetic calcium phosphate (BioCaP) containing BMP-2 in different ways. Eight groups—each containing samples of 0.25 g CHA—were formed and coated with, respectively, BioCaP with internally incorporated BMP-2 in concentrations of 1, 5, 10, 20, 40 and 60 µg per sample, and the two control groups with BioCaP only and BioCaP with 20 µg of adsorbed BMP-2 per sample. The samples were implanted subcutaneously in 27 male Wistar rats. The histological results show that there is no bone formation in the group in which no BMP-2 was included. All samples with BioCaP containing BMP-2 show bone formation. The group with 20 µg of adsorbed BMP-2 per sample shows the least bone formation. Coating-incorporated BMP-2 is more efficient in inducing bone formation than adsorbed BMP-2. The group with 5 µg of coating-incorporated BMP-2 per sample shows the most bone formation. Increasing the amount of coating-incorporated BMP-2 up to 60 µg does not improve ectopic bone formation.


Bone ◽  
2005 ◽  
Vol 36 (6) ◽  
pp. 1086-1093 ◽  
Author(s):  
D LENIHOUANNEN ◽  
G DACULSI ◽  
A SAFFARZADEH ◽  
O GAUTHIER ◽  
S DELPLACE ◽  
...  

2017 ◽  
Vol 77 ◽  
pp. 136-141 ◽  
Author(s):  
Lijia Cheng ◽  
Shuo Yan ◽  
Jiang Zhu ◽  
Peiling Cai ◽  
Ting Wang ◽  
...  

PeerJ ◽  
2018 ◽  
Vol 6 ◽  
pp. e4771 ◽  
Author(s):  
Mathijs G.A. Broeren ◽  
Irene Di Ceglie ◽  
Miranda B. Bennink ◽  
Peter L.E.M. van Lent ◽  
Wim B. van den Berg ◽  
...  

Objective Tumor necrosis factor-inducible gene 6 (TSG-6) has anti-inflammatory and chondroprotective effects in mouse models of inflammatory arthritis. Because cartilage damage and inflammation are also observed in osteoarthritis (OA), we determined the effect of viral overexpression of TSG-6 in experimental osteoarthritis. Methods Bone marrow-derived cells were differentiated to multinucleated osteoclasts in the presence of recombinant TSG-6 or after transduction with a lentiviral TSG-6 expression vector. Multi-nucleated osteoclasts were analyzed after tartrate resistant acid phosphatase staining and resorption activity was determined on dentin slices. Collagenase-induced osteoarthritis (CIOA) was induced in C57BL/6 mice after intra-articular injection of an adenoviral TSG-6 or control luciferase expression vector. Inflammation-related protease activity was measured using bioluminescent Prosense probes. After a second adenovirus injection, cartilage damage was assessed in histological sections stained with Safranin-O. Ectopic bone formation was scored in X-ray images of the affected knees. Results TSG-6 did not inhibit the formation of multi-nucleated osteoclasts, but caused a significant reduction in the resorption activity on dentin slices. Adenoviral TSG-6 gene therapy in CIOA could not reduce the cartilage damage compared to the luciferase control virus and no significant difference in inflammation-related protease activity was noted between the TSG-6 and control treated group. Instead, X-ray analysis and histological analysis revealed the presence of ectopic bone formation in the TSG-6 treated group. Conclusion Gene therapy based on the expression of TSG-6 could not provide cartilage protection in experimental osteoarthritis, but instead resulted in increased ectopic bone formation.


Biomaterials ◽  
2012 ◽  
Vol 33 (7) ◽  
pp. 2086-2096 ◽  
Author(s):  
Roberta Tasso ◽  
Massimiliano Gaetani ◽  
Erica Molino ◽  
Angela Cattaneo ◽  
Massimiliano Monticone ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document